X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15635) 15635
Publication (1678) 1678
Book Review (91) 91
Book Chapter (62) 62
Conference Proceeding (17) 17
Magazine Article (12) 12
Dissertation (8) 8
Book / eBook (3) 3
Data Set (2) 2
Newsletter (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8985) 8985
animals (7976) 7976
index medicus (6828) 6828
male (6690) 6690
indoles - pharmacology (6551) 6551
female (4506) 4506
indoles - therapeutic use (3547) 3547
rats (3397) 3397
mice (2783) 2783
pharmacology & pharmacy (2681) 2681
middle aged (2571) 2571
adult (2154) 2154
indoles - administration & dosage (1948) 1948
aged (1867) 1867
oncology (1851) 1851
cancer (1610) 1610
dose-response relationship, drug (1527) 1527
indoles (1484) 1484
indoles - adverse effects (1405) 1405
indoles - chemistry (1380) 1380
biochemistry & molecular biology (1320) 1320
analysis (1174) 1174
cell line, tumor (1120) 1120
expression (1092) 1092
rats, sprague-dawley (1091) 1091
treatment outcome (1060) 1060
time factors (1046) 1046
indoles - pharmacokinetics (1041) 1041
blood pressure - drug effects (1012) 1012
apoptosis (989) 989
neurosciences (980) 980
research (959) 959
enzyme inhibitors - pharmacology (956) 956
pyrroles - therapeutic use (954) 954
cell biology (935) 935
article (922) 922
indoles - metabolism (917) 917
cells, cultured (902) 902
sunitinib (814) 814
care and treatment (810) 810
antineoplastic agents - therapeutic use (803) 803
indoles - blood (802) 802
disease models, animal (797) 797
cells (753) 753
activation (749) 749
in vitro techniques (743) 743
apoptosis - drug effects (740) 740
chemistry, medicinal (731) 731
indole (716) 716
rats, wistar (714) 714
in-vitro (713) 713
pyrroles - pharmacology (702) 702
angiogenesis (661) 661
double-blind method (661) 661
proteins (658) 658
antineoplastic agents - pharmacology (638) 638
physiology (632) 632
research article (632) 632
therapy (625) 625
cell proliferation - drug effects (610) 610
inhibition (597) 597
mice, inbred c57bl (596) 596
physiological aspects (590) 590
tumors (577) 577
medicine (572) 572
phosphorylation (572) 572
health aspects (568) 568
in-vivo (568) 568
administration, oral (564) 564
structure-activity relationship (561) 561
aged, 80 and over (558) 558
hematology (541) 541
hypertension (540) 540
inflammation (540) 540
protein kinase c - antagonists & inhibitors (540) 540
fluvastatin (539) 539
drug therapy (533) 533
medicine & public health (533) 533
carcinoma, renal cell - drug therapy (530) 530
signal transduction - drug effects (526) 526
cell line (525) 525
endothelial growth-factor (518) 518
maleimides - pharmacology (511) 511
signal transduction (509) 509
cardiac & cardiovascular systems (507) 507
kidney neoplasms - drug therapy (502) 502
dogs (497) 497
pharmacokinetics (497) 497
pharmacology (488) 488
hypertension - drug therapy (485) 485
peripheral vascular disease (484) 484
tyrosine kinase inhibitor (484) 484
pyrroles - adverse effects (479) 479
cell survival - drug effects (478) 478
multidisciplinary sciences (475) 475
antineoplastic agents (466) 466
indoles - chemical synthesis (460) 460
metastasis (457) 457
kinetics (456) 456
fatty acids, monounsaturated - therapeutic use (453) 453
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (15243) 15243
Russian (98) 98
French (83) 83
German (76) 76
Chinese (60) 60
Japanese (52) 52
Italian (20) 20
Polish (17) 17
Spanish (16) 16
Hungarian (11) 11
Czech (9) 9
Danish (3) 3
Korean (2) 2
Norwegian (2) 2
Croatian (1) 1
Dutch (1) 1
Portuguese (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 11/2012, Volume 30, Issue 32, pp. 4017 - 4025
Therapeutic drug monitoring (TDM) provides valuable guidance for dose adjustment of antibiotics, immunosuppressives, antiepileptics, and other drugs, but its... 
ANTI-CD20 MONOCLONAL-ANTIBODY | ONCOLOGY | FC-GAMMA-RIIIA | PROGRESSION-FREE SURVIVAL | MULTICENTER PHASE-II | SQUAMOUS-CELL CARCINOMA | TYROSINE KINASE INHIBITOR | ENDOTHELIAL GROWTH-FACTOR | SUNITINIB MALATE SU11248 | CHRONIC MYELOID-LEUKEMIA | IMATINIB PLASMA-LEVELS | Neoplasms - metabolism | Niacinamide - analogs & derivatives | Piperazines - administration & dosage | Thiazoles - blood | Injections, Intravenous | Area Under Curve | Pyrimidines - blood | Humans | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Half-Life | Thiazoles - administration & dosage | Phenylurea Compounds | Antineoplastic Agents - administration & dosage | Benzenesulfonates - administration & dosage | Drug Monitoring - methods | Indoles - administration & dosage | Antibodies, Monoclonal - blood | Antibodies, Monoclonal, Humanized | Neoplasms - blood | Antineoplastic Agents - adverse effects | Pyrroles - administration & dosage | Benzenesulfonates - blood | Antineoplastic Agents - pharmacokinetics | Cetuximab | Piperazines - blood | Everolimus | Molecular Targeted Therapy - methods | Dasatinib | Sirolimus - analogs & derivatives | Pyridines - administration & dosage | Pyrimidines - administration & dosage | Indoles - blood | Rituximab | Pyrroles - blood | Sirolimus - blood | Evidence-Based Medicine | Imatinib Mesylate | Neoplasms - drug therapy | Sirolimus - administration & dosage | Antibodies, Monoclonal, Murine-Derived - blood | Pyridines - blood | Animals | Antibodies, Monoclonal - administration & dosage | Antineoplastic Agents - blood | Benzamides
Journal Article
Journal Article
International Journal of Cancer, ISSN 0020-7136, 03/2012, Volume 130, Issue 6, pp. 1357 - 1366
The MET oncogene is amplified in a fraction of human gastric carcinoma cell lines, with consequent overexpression and constitutive activation of the... 
oncogene addiction | surrogate biomarkers | targeted therapies | Met receptor | CARCINOMA CELLS | NECROSIS-FACTOR-ALPHA | PLASMINOGEN-ACTIVATOR RECEPTOR | INTERLEUKIN-8 | IN-VITRO | ONCOLOGY | AUTOCRINE GROWTH-FACTOR | C-MET | PROSTATE-CANCER | UROKINASE RECEPTOR | CELL-LINE | Mannose-Binding Lectins - metabolism | Proto-Oncogene Proteins c-met - metabolism | Interleukin-8 - genetics | Membrane Glycoproteins - metabolism | Humans | Stomach Neoplasms - metabolism | Chemokine CXCL1 - genetics | Gene Expression Profiling | Sulfones - pharmacology | Interleukin-6 - blood | Biomarkers, Tumor - metabolism | Female | Indoles - pharmacology | Interleukin-8 - metabolism | Chemokine CXCL1 - metabolism | Interleukin-8 - blood | Interleukin-6 - metabolism | Stomach Neoplasms - genetics | Interleukin-6 - genetics | Proto-Oncogene Proteins c-met - antagonists & inhibitors | Membrane Glycoproteins - blood | Receptors, Cell Surface - metabolism | Receptors, Cell Surface - blood | Chemokine CXCL1 - blood | Stomach Neoplasms - drug therapy | Membrane Glycoproteins - genetics | Proto-Oncogene Proteins c-met - genetics | Biomarkers, Tumor - blood | Xenograft Model Antitumor Assays | Animals | Mannose-Binding Lectins - genetics | Mannose-Binding Lectins - blood | Stomach Neoplasms - blood | Mice, Nude | Proteomics | Cell Line, Tumor | Biomarkers, Tumor - genetics | Mice | Receptors, Cell Surface - genetics | Biomarkers | Kinases | Gene expression | Tumors
Journal Article
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2009, Volume 45, Issue 11, pp. 1959 - 1968
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 3/2009, Volume 106, Issue 10, pp. 3698 - 3703
Journal Article
ChemBioChem, ISSN 1439-4227, 04/2018, Volume 19, Issue 7, pp. 696 - 705
Non‐cationic and amphipathic indoloazepinone‐constrained (Aia) oligomers have been synthesized as new vectors for intracellular delivery. The conformational... 
aminoindoloazepinones | peptidomimetics | blood–brain barrier | drug delivery | cell-penetrating peptides | blood-brain barrier | CHEMISTRY, MEDICINAL | PHOSPHOLIPID-VESICLES | DRUG-DELIVERY | BIOCHEMISTRY & MOLECULAR BIOLOGY | MOLECULAR TRANSPORTERS | BIOLOGICAL-MEMBRANES | HUMAN IMMUNODEFICIENCY VIRUS | STRUCTURAL REQUIREMENTS | IN-VIVO | INTRACELLULAR DELIVERY | SECONDARY STRUCTURE | HYBRID PEPTIDES | Drug Carriers - metabolism | Peptidomimetics - chemical synthesis | Peptidomimetics - metabolism | Humans | Molecular Conformation | Azepines - chemical synthesis | Cell Membrane Permeability | Indoles - chemical synthesis | Drug Carriers - toxicity | Indoles - toxicity | Drug Carriers - chemical synthesis | Blood-Brain Barrier - metabolism | Cell-Penetrating Peptides - toxicity | Indoles - metabolism | Animals | Cattle | Azepines - metabolism | Cell Line, Tumor | Cell Membrane - metabolism | Cell-Penetrating Peptides - chemical synthesis | Azepines - toxicity | Peptidomimetics - toxicity | Cell-Penetrating Peptides - metabolism | Oligomers | Drugs | Drug delivery systems | Peptides | Analysis | Nuclear magnetic resonance spectroscopy | Permeability | Glycine | Vehicles | Brain | Nuclear magnetic resonance--NMR | Indole | Hydrophobicity | Blood | Circular dichroism | Magnetic resonance spectroscopy | Penetration | Blood-brain barrier | Diffusion barriers | Dichroism | NMR spectroscopy
Journal Article
Clinica Chimica Acta, ISSN 0009-8981, 07/2017, Volume 470, pp. 8 - 13
Journal Article